← Eichor
Study identifier: NCT06135753 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Psychosomatic Intervention in Fibromyalgia.

Condition: Fibromyalgia  ·  Sponsor: University of Florence

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Fibromyalgia is a widespread musculoskeletal pain syndrome. It is characterized by physical manifestations which are also the expression of a psychological distress as well as specific illness attitudes and behaviors. Indeed, it is considered a psychosomatic disorder. In this framework, we hypothesize the clinical utility of a psychosomatic assessment guided by rheumatologists and clinical psychologists (Study 1) and the utility of an integrated multidisciplinary psychosomatic intervention based on cognitive restructuring/psychoeducation followed by museum therapy (Study 2). For Study 1 a cross-sectional observation study will be implemented, for Study 2 a randomized controlled trial will be applied.

This description comes directly from the study's public registry record.

Talk to the study team

Fiammetta Cosci, MD, Prof.ssa  ·  0552755066 Ext. 0039  ·  fiammetta.cosci@unifi.it

Always discuss trial participation with your own doctor first.

Locations (1)

Rheumtoi Unit, Academic Hospital CareggiFlorence, Italia/Firenze, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06135753